Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis
- 6 February 2007
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 56 (4) , 612-616
- https://doi.org/10.1016/j.jaad.2006.06.044
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- New world cutaneous leishmaniasis in travellersThe Lancet Infectious Diseases, 2006
- Electrocardiographic and biochemical adverse effects of sodium stibogluconate during treatment of cutaneous and mucosal leishmaniasis among returned travellersTransactions of the Royal Society of Tropical Medicine and Hygiene, 2006
- Localized cutaneous leishmaniasis imported into Paris: a review of 39 casesInternational Journal of Dermatology, 2004
- Treatment of cutaneous leishmaniasis among travellersJournal of Antimicrobial Chemotherapy, 2004
- Experience with New World cutaneous leishmaniasis in travelersJournal of the American Academy of Dermatology, 2003
- PCR diagnosis and characterization of Leishmania in local and imported clinical samplesPublished by Elsevier ,2003
- Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patientsFundamental & Clinical Pharmacology, 2003
- LeishmaniasisThe Lancet, 1999
- Safety and Efficacy of Intravenous Sodium Stibogluconate in the Treatment of Leishmaniasis: Recent U.S. Military ExperienceClinical Infectious Diseases, 1998
- Recommendations for Treating Leishmaniasis with Sodium Stibogluconate (Pentostam) and Review of Pertinent Clinical StudiesThe American Journal of Tropical Medicine and Hygiene, 1992